- Business
- Exlites Holdings International, Inc. is a healthcare company engaged in the manufacturing and distribution of medical products and consumer healthcare solutions. Its core product offerings include therapeutic pain management systems, exercise equipment, weight loss devices, and deep vein thrombosis (DVT) prevention systems. The company sells proprietary patented and patent-pending medical devices such as transcutaneous electrical nerve stimulation (TENS) units, electronic muscle stimulation (EMS) units, various bracing products, and other related healthcare products. Exlites also provides contract manufacturing services for medical and consumer health products. The company operates multiple distribution channels including consumer distributors, medical distributors, catalogs, retailers, and direct-to-consumer venues. It serves global markets through its diversified distribution network. Founded in 1979, Exlites Holdings International is headquartered in Tampa, Florida.
In recent developments, Exlites Holdings International has strategically expanded through acquisitions, notably the agreement to acquire Devon Orthopedic Implants LLC, which broadens its product portfolio in orthopedic implants and related medical devices. The company has also emphasized innovation and technology leadership with a unique portfolio of proprietary patented and patent-pending products, aiming to lead the medical device industry through high-quality, efficient, and innovative solutions. Its business strategy focuses on deepening customer relationships, enhancing value-added services, and expanding distribution channels while maintaining a strong commitment to product development for the medical and home care markets. The company continues to innovate in both medical device and electric vehicle range extender segments, reflecting a diversification in its product lines and operational focus.
Exlites Holdings International operates primarily in the medical device and consumer healthcare industries, targeting patient care with therapeutic and preventive medical products. Its geographic operations are centered in the United States, with an expanding global footprint through distributor partnerships. The company maintains a commitment to compliance with FDA 510(k) clearance requirements for several of its product classes, ensuring regulatory adherence. The company is publicly traded under the ticker EXHI and leverages its history since 1979 and experienced management to navigate the healthcare sector's complexities while focusing on long-term growth through innovation, strategic acquisitions, and strong market partnerships. Its headquarters are located in Tampa, Florida.